dc.contributor.author |
Abchee A. |
dc.contributor.author |
Puzantian H. |
dc.contributor.author |
Azar S.T. |
dc.contributor.author |
Shbaklo H. |
dc.contributor.author |
Nasrallah A. |
dc.contributor.author |
Sawaya F.J. |
dc.contributor.author |
Alam S. |
dc.contributor.author |
Zalloua P.A. |
dc.contributor.editor |
|
dc.date |
May-2006 |
dc.date.accessioned |
2017-10-05T15:46:56Z |
dc.date.available |
2017-10-05T15:46:56Z |
dc.date.issued |
2006 |
dc.identifier |
10.1016/j.thromres.2005.05.022 |
dc.identifier.isbn |
|
dc.identifier.issn |
00493848 |
dc.identifier.uri |
http://hdl.handle.net/10938/18566 |
dc.description.abstract |
Background: Coronary artery disease (CAD) is one of the major causes of morbidity and mortality in the world. The disease is determined by many risk factors such as age, gender, diabetes, dyslipidemia, smoking, as well as elevated serum levels of lipoprotein (a) (Lp(a)), homocysteine, C-reactive protein (CRP) and uric acid. In this study, we evaluated the association of biologic and metabolic parameters with CAD in a group of Lebanese patients. Methods: Three hundred patients were recruited for the study. Biologic and blood metabolic parameters were measured. Patients were then divided into 3 groups according to their catheterization result: 0percent stenosis (controls), 50percent stenosis and ≥ 50percent stenosis. Results: Hyperlipidemias, CRP, homocysteine and uric acid levels in CAD patients were not different from those of the controls. However, age, elevated fasting blood glucose (FBG) and elevated serum Lp(a) levels were found to be strong independent predictors of CAD in our study population. Association with CAD was also shown for gender, hypertension, diabetes and family history of CAD. Conclusion: We report the importance of serum Lp(a) levels and FBG in the prediction and prevention of CAD in our population. © 2005 Elsevier Ltd. All rights reserved. |
dc.format.extent |
|
dc.format.extent |
Pages: (631-637) |
dc.language |
English |
dc.publisher |
OXFORD |
dc.relation.ispartof |
Publication Name: Thrombosis Research; Publication Year: 2006; Volume: 117; no. 6; Pages: (631-637); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Predictors of coronary artery disease in the Lebanese population |
dc.type |
Article |
dc.contributor.affiliation |
Abchee, A., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Puzantian, H., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Azar, S.T., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Shbaklo, H., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Nasrallah, A., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Sawaya, F.J., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Alam, S., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Zalloua, P.A., Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon, Harvard School of Public Health, Boston, United States |
dc.contributor.authorAddress |
Zalloua, P.A.; Department of Internal Medicine, American University, Beirut Medical Center, Beirut, Lebanon; email: pz02@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Obstetrics and Gynecology; |
dc.contributor.authorDepartment |
Obstetrics and Gynecology |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
pz02@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Abchee, A |
dc.contributor.authorInitials |
Puzantian, H |
dc.contributor.authorInitials |
Azar, ST |
dc.contributor.authorInitials |
Shbaklo, H |
dc.contributor.authorInitials |
Nasrallah, A |
dc.contributor.authorInitials |
Sawaya, FJ |
dc.contributor.authorInitials |
Alam, S |
dc.contributor.authorInitials |
Zalloua, PA |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Zalloua, PA (reprint author), Amer Univ Beirut, Dept Internal Med, Med Ctr, POB 11-0236, Beirut, Lebanon. |
dc.contributor.authorResearcherID |
王, 强-F-4212-2011 |
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Acarturk E, 2004, CLIN CHIM ACTA, V339, P123, DOI 10.1016-j.cccn.2003.10.001; Albert AL, 2004, BMC CELL BIOL, V5, DOI 10.1186-1471-2121-5-22; American Diabetes Association, 1998, DIABETES CARE, V21, P1551; Anderson JL, 1998, J AM COLL CARDIOL, V32, P35, DOI 10.1016-S0735-1097(98)00203-4; Antonio CM, 1997, BIOCHEM J, V328, P165; Aydenian H, 1999, ANN BIOL CLIN-PARIS, V57, P697; Bhopal R, 1999, BRIT MED J, V319, P215; Bickel C, 2002, AM J CARDIOL, V89, P12, DOI 10.1016-S0002-9149(01)02155-5; Boufidou AI, 2004, CURR MED RES OPIN, V20, P175, DOI 10.1185-030079903125002856; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001-jama.274.13.1049; BRAND FN, 1985, AM J EPIDEMIOL, V121, P11; Cooke JP, 1997, ANNU REV MED, V48, P489; Corella Dolores, 2004, Curr Atheroscler Rep, V6, P186, DOI 10.1007-s11883-004-0031-8; Danesh J, 2000, CIRCULATION, V102, P1082; Dangas G, 1999, AM J CARDIOL, V83, P583, DOI 10.1016-S0002-9149(98)00917-5; Durand P, 2001, LAB INVEST, V81, P645; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637; Gazzaruso C, 2001, DIABETIC MED, V18, P589, DOI 10.1046-j.1464-5491.2001.00536.x; Gazzaruso C, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186-1475-2840-1-5; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001-jama.263.21.2893; Haffner SM, 2000, CIRCULATION, V101, P975; ISRAELSSON B, 1988, ATHEROSCLEROSIS, V71, P227, DOI 10.1016-0021-9150(88)90147-5; KOSTNER GM, 1981, ATHEROSCLEROSIS, V38, P51, DOI 10.1016-0021-9150(81)90103-9; Kukreja N, 2004, INT J CARDIOL, V97, P77, DOI 10.1016-j.ijcard.2003.08.012; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161-01.ATV.0000022850.59845.E0; Faglia E, 1997, AM J CARDIOL, V79, P134; National Cholesterol Education Program, 1994, CIRCULATION, V89, P1333; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701; Paultre F, 2000, ARTERIOSCL THROM VAS, V20, P2619; Refsum H, 1998, ANNU REV MED, V49, P31; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016-S0002-9149(99)00491-9; RUIZ J, 1994, DIABETOLOGIA, V37, P585, DOI 10.1007-BF00403377; Schwartzman RA, 1998, J AM COLL CARDIOL, V31, P1260, DOI 10.1016-S0735-1097(98)00096-5; Sibai AM, 2003, OBES RES, V11, P1353, DOI 10.1038-oby.2003.183; Gavin JR, 1997, DIABETES CARE, V20, P1183; UBBINK JB, 1991, KLIN WOCHENSCHR, V69, P527, DOI 10.1007-BF01649290; Upchurch GR, 1997, J BIOL CHEM, V272, P17012, DOI 10.1074-jbc.272.27.17012; Wannamethee SG, 1997, HEART, V78, P147; Watson Karol E, 2004, Rev Cardiovasc Med, V5 Suppl 3, pS14; WEINER DA, 1991, AM J CARDIOL, V68, P729, DOI 10.1016-0002-9149(91)90644-Z; WILCKEN DEL, 1983, METABOLISM, V32, P363, DOI 10.1016-0026-0495(83)90045-8 |
dc.description.citedCount |
11 |
dc.description.citedTotWOSCount |
8 |
dc.description.citedWOSCount |
8 |
dc.format.extentCount |
7 |
dc.identifier.articleNo |
|
dc.identifier.coden |
THBRA |
dc.identifier.pubmedID |
15985286 |
dc.identifier.scopusID |
33646075437 |
dc.identifier.url |
|
dc.publisher.address |
THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Thromb. Res. |
dc.relation.ispartOfIssue |
6 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Thrombosis Research |
dc.relation.ispartofPubTitleAbbr |
Thromb. Res. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
117 |
dc.source.ID |
WOS:000237369500004 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Coronary artery disease |
dc.subject.otherAuthKeyword |
Fasting blood glucose |
dc.subject.otherAuthKeyword |
Lipoprotein (a) |
dc.subject.otherChemCAS |
C reactive protein, 9007-41-4 |
dc.subject.otherChemCAS |
glucose, 50-99-7, 84778-64-3 |
dc.subject.otherChemCAS |
homocysteine, 454-28-4, 6027-13-0 |
dc.subject.otherChemCAS |
uric acid, 69-93-2 |
dc.subject.otherChemCAS |
Blood Glucose |
dc.subject.otherChemCAS |
Lipoprotein(a) |
dc.subject.otherIndex |
C reactive protein |
dc.subject.otherIndex |
glucose |
dc.subject.otherIndex |
homocysteine |
dc.subject.otherIndex |
lipoprotein A |
dc.subject.otherIndex |
uric acid |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
age distribution |
dc.subject.otherIndex |
aged |
dc.subject.otherIndex |
amino acid blood level |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
cardiovascular risk |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
coronary artery disease |
dc.subject.otherIndex |
diabetes mellitus |
dc.subject.otherIndex |
disease association |
dc.subject.otherIndex |
family history |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
hyperglycemia |
dc.subject.otherIndex |
hyperlipidemia |
dc.subject.otherIndex |
hypertension |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
lipoprotein blood level |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
prediction |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
risk assessment |
dc.subject.otherIndex |
sex difference |
dc.subject.otherIndex |
uric acid blood level |
dc.subject.otherIndex |
Aged |
dc.subject.otherIndex |
Blood Glucose |
dc.subject.otherIndex |
Case-Control Studies |
dc.subject.otherIndex |
Coronary Angiography |
dc.subject.otherIndex |
Coronary Arteriosclerosis |
dc.subject.otherIndex |
Fasting |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Lipoprotein(a) |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Predictive Value of Tests |
dc.subject.otherIndex |
Risk Factors |
dc.subject.otherKeywordPlus |
CARDIOVASCULAR RISK-FACTORS |
dc.subject.otherKeywordPlus |
SILENT-MYOCARDIAL-ISCHEMIA |
dc.subject.otherKeywordPlus |
C-REACTIVE PROTEIN |
dc.subject.otherKeywordPlus |
SERUM URIC-ACID |
dc.subject.otherKeywordPlus |
HEART-DISEASE |
dc.subject.otherKeywordPlus |
DIABETES-MELLITUS |
dc.subject.otherKeywordPlus |
APOLIPOPROTEIN(A) PHENOTYPES |
dc.subject.otherKeywordPlus |
LIPOPROTEIN(A) LEVELS |
dc.subject.otherKeywordPlus |
PLASMA HOMOCYSTEINE |
dc.subject.otherKeywordPlus |
VASCULAR-DISEASE |
dc.subject.otherWOS |
Hematology |
dc.subject.otherWOS |
Peripheral Vascular Disease |